Medication info
Tenetrium Extended Release Tablet 10/500 mg

Tenetrium Extended Release Tablet 10/500 mg

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletTeneligliptin Hydrochloride Hydrate›12.98mg / 1 tablet
Manufacturer / importer
Kyungdong Pharmaceutical Co., Ltd.
Appearance
Orange colored, biconvex, oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202202807 · Approved 2022.07.06 · Insurance code 648104780

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment with this medicine may be started at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other antihyperglycemic agents. Because such a switch may cause changes in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Ingredients

Manufacturer
Kyungdong Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes

View approved original text

This medication is used to help patients with type 2 diabetes control their blood sugar levels in conjunction with diet and exercise regimens. The combination of teneligliptin and metformin effectively lowers blood sugar levels. This leads to improved blood glucose control, aiding in the management of diabetes and supporting patients in maintaining a healthier blood glucose status in their daily lives. This medication offers a positive effect in the treatment of diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose should be titrated gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets together once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's current dose of metformin. For patients switching from combination therapy with teneligliptin and metformin to this medicine, treatment with this medicine may be started at the current doses of teneligliptin and metformin. When switching from immediate-release to extended-release metformin, glycemic control should be closely monitored and the dose adjusted as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other antihyperglycemic agents. Because such a switch may cause changes in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain the extended-release properties, swallow this medicine whole; do not split, crush, grind, or chew it.

Precautions

This medication is used for the treatment of diabetes and helps in blood sugar control. It can rarely cause a very serious side effect called lactic acidosis, which is highly dangerous. Lactic acidosis is a condition where there is an excessive buildup of lactic acid in the body, leading to acidity, which can be life-threatening if not treated. Renal function is very important during the course of this medication. Patients with impaired kidney function should not use this medication and should regularly check their renal function. Patients with heart conditions or heart failure, as well as those in serious conditions such as acute myocardial infarction or septicemia, should also refrain from using this medication. This medication should be stopped at least 48 hours before tests using iodine-based contrast agents and should only be resumed once renal function is confirmed to be normal after the tests. It is recommended that this medication is not used in pregnant women or those who may become pregnant. Hypoglycemia may occur when used in conjunction with other diabetes medications or insulin, so patients should be well aware of the symptoms and handling of hypoglycemia. During the use of this medication, if severe abdominal pain, vomiting, shortness of breath, or weakness appears, it is imperative to consult a physician immediately. Patients with impaired liver or lung function should exercise caution. Long-term use may lead to decreased levels of vitamin B12, hence regular blood tests are necessary. Older adults may experience decreased kidney function, requiring dosage adjustments and regular checks of renal function. Taking this medication with alcohol increases the risk of side effects, so alcohol consumption should be avoided. It is advisable for breastfeeding women to avoid taking this medication and consult a doctor if they need to take it. In case of overdose, one should immediately visit a healthcare facility for appropriate treatment, and hemodialysis may be necessary. This medication should be kept out of reach of children and should not be transferred to other containers. During the use of this medication, regular physician visits are necessary, and any unusual symptoms should be reported immediately.

Side effects

Severe lactic acidosis, hypoglycemia, constipation, intestinal obstruction, liver dysfunction, interstitial pneumonia, bullous pemphigoid, acute pancreatitis, dizziness, abdominal distension, abdominal discomfort, nausea, abdominal pain, bloating, stomatitis, gastric polyps, colonic polyps, duodenal ulcer, gastroesophageal reflux disease, diarrhea, decreased appetite, increased amylase, increased lipase, elevated AST(GOT), elevated ALT(GPT), elevated GGT, elevated ALP, proteinuria, ketonuria, potential hematuria, eczema, rash, itching, allergic dermatitis, arthralgia, increased CK(CPK), elevated serum potassium levels, malaise, allergic rhinitis, elevated serum uric acid, peripheral edema, hypoglycemia, tremor, headache, weakness, hunger, fatigue, facial edema, dyspepsia, nausea, viral upper respiratory infection, herpes zoster, rhinitis, sweating, diabetic retinopathy, reduced vision, cough, pulmonary congestion, shortness of breath, drug overdose, prostatic hyperplasia, headache, diarrhea, chronic gastritis, irritable bowel syndrome, fatigue, cerebral infarction, hyperglycemia, liver biopsy, neutropenia, abnormal blood sugar, increased blood sugar, increased blood pressure, hepatic coma, lumbar spinal canal stenosis, spinal disc herniation, disc disorder of the spine, spinal ligament ossification, foraminal stenosis of the spine, rotator cuff syndrome, hypercholesterolemia, hypertension, cough, insomnia, hives, sensory disorders, decreased sensation, tension headache, peripheral neuropathy, facial paralysis, sciatica, orthostatic dizziness, muscle weakness, back pain, limb pain, tendinitis, cervical pain, bone pain, osteoarthritis, osteoporosis, muscle spasms, foot deformities, hypertrophic osteoarthropathy, bursitis, spinal osteoarthritis, postmenopausal osteoporosis, chest discomfort, fever, chills, generalized edema, injection site inflammation, ureteral stones, dysuria, renal cysts, nocturia, depression, anxiety disorder due to general medical condition, ovarian cysts, vulvar pruritus, menopausal symptoms, toxic hepatitis, chronic cholecystitis, non-alcoholic fatty liver disease, alcoholic liver disease, eyelid damage, ligament sprain, lip damage, contusion, cataract, glaucoma, blurred vision, age-related macular degeneration, hyperthyroidism, hyperparathyroidism, coronary artery disease, unstable angina, angina pectoris, otalgia, dizziness, iron deficiency anemia, food allergy

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is recommended to store it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Orange colored, biconvex, oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.